| ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |
| CDSN |
Q15517
|
corneodesmosin
|
|
0.46 |
0.585 |
0.731 |
| CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| DDX39B |
Q13838
|
DExD-box helicase 39B
|
|
1.00 |
0.641 |
0.808 |
| GNL1 |
P36915
|
G protein nucleolar 1 (putative)
|
|
1.00 |
0.805 |
0.423 |
| HCG22 |
E2RYF7
|
HLA complex group 22 (gene/pseudogene)
|
|
|
0.736 |
0.423 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| LST1 |
O00453
|
leukocyte specific transcript 1
|
|
1.1E-03 |
0.792 |
0.308 |
| LTB |
Q06643
|
lymphotoxin beta
|
Signaling
|
9.6E-11 |
0.555 |
0.769 |
| MUC22 |
E2RYF6
|
mucin 22
|
|
1.4E-02 |
0.729 |
0.500 |
| NELFE |
P18615
|
negative elongation factor complex member E
|
|
6.9E-03 |
0.686 |
0.500 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
| SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
| TAP2 |
Q03519
|
transporter 2, ATP binding cassette subfamily B member
|
Transporter
|
6.9E-11 |
0.517 |
0.808 |
| TCF19 |
Q9Y242
|
transcription factor 19
|
|
9.4E-04 |
0.674 |
0.692 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |